Beta Bionics initiates coverage with buy rating; target price $30
BBNX•Jefferies initiated coverage of Beta Bionics with a buy rating and a $30 target price.
Related News
MiniMed Group Inc: Jefferies initiates coverage with hold rating; target price $22
MMED•
US reportedly reverses course on Britain's testing of AI models
QQQ•
GoDaddy cut to sector perform from outperform at RBC
GDDY•
Piper Sandler cuts Curbline Properties Corp. target price to $38 from $39
CURB•
NMI Holdings, Inc.: JPMorgan cuts target price to $45 from $50
NMIH•